These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 18928152

  • 1. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
    Deliyska B, Tsacheva I, Radanova M, Stoianova V, Tchorbadjieva M, Dobreva N.
    Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
    [Abstract] [Full Text] [Related]

  • 2. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y, Zhou W, Yu F, Fang Q, Yang HZ, Zhao MH.
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [Abstract] [Full Text] [Related]

  • 3. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U.
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 5. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V, Petrova S, Tchorbadjieva M, Deliyska B, Vasilev V, Tsacheva I.
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [Abstract] [Full Text] [Related]

  • 6. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 8. Anti-Idiotype scFv Localizes an Autoepitope in the Globular Domain of C1q.
    Todorova N, Rangelov M, Bogoeva V, Stoyanova V, Yordanova A, Nikolova G, Georgiev H, Dimitrova D, Mohedin S, Stoyanova K, Tsacheva I.
    Int J Mol Sci; 2021 Aug 01; 22(15):. PubMed ID: 34361054
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 01; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 10. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 11. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 12. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G.
    Ann N Y Acad Sci; 2009 Sep 02; 1173():47-51. PubMed ID: 19758131
    [Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 02; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 14. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A, Pipi E, Soufleros K.
    Ann N Y Acad Sci; 2009 Sep 02; 1173():243-51. PubMed ID: 19758158
    [Abstract] [Full Text] [Related]

  • 15. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA.
    Autoimmunity; 2013 May 02; 46(3):205-14. PubMed ID: 23331132
    [Abstract] [Full Text] [Related]

  • 16. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R, Daha MR.
    Mol Immunol; 2007 Jan 02; 44(1-3):133-8. PubMed ID: 16870257
    [Abstract] [Full Text] [Related]

  • 17. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D, Roumenina LT, Wan H, Osthoff M, Schaller M, Trendelenburg M.
    Arthritis Rheum; 2012 Nov 02; 64(11):3706-14. PubMed ID: 22740328
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y, Wu X, Shan G, Zhang X.
    Lupus; 2012 Sep 02; 21(10):1088-97. PubMed ID: 22777943
    [Abstract] [Full Text] [Related]

  • 19. Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease.
    Stoyanova V, Tchorbadjieva M, Deliyska B, Vasilev V, Tsacheva I.
    Immunol Lett; 2012 Sep 02; 148(1):69-76. PubMed ID: 22981967
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.
    Grootscholten C, Dieker JW, McGrath FD, Roos A, Derksen RH, van der Vlag J, Daha MR, Berden JH.
    Ann Rheum Dis; 2007 May 02; 66(5):693-6. PubMed ID: 17135217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.